About Index Trending news
Analyze
Pricing
Blueprint Medicines

Blueprint Medicines

Work at Blueprint Medicines? Add yourself to this profile

Blueprint Medicines

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers

Elsewhere

Alexa global traffic share

Twitter followers

08 Dec 2016
$125,000,000
Post-IPO debt

Biotech Day on Twitter

Twitter
12 Nov 2014
$50,000,000
Venture capital (Series C)
07 Jan 2014
$25,000,000
Venture capital (Series B)
11 Apr 2011
$40,000,000
Venture capital (Series A)